Home › Funds › Octagon Capital Advisors LP › DFTX

Octagon Capital Advisors LP position in DFTX

DEFINIUM THERAPEUTICS INC · Health Care

Octagon Capital Advisors LP reported holding 2,511,000 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$95.6M, representing 12.73% of its reported portfolio and ranking #3 among its reported holdings. Octagon Capital Advisors LP has disclosed DFTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)2.51M sh
Reported value held$95.57M
Portfolio Weight12.73%
First reportedQ1 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Octagon Capital Advisors LP's DFTX position evolved

Octagon Capital Advisors LP first disclosed a stake in DFTX in Q1 2026 at 2,440,000 shares (US$46.1M). The position peaked in Q2 2026 at 2,950,000 shares, worth US$138.8M. Across 3 filings, Octagon Capital Advisors LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,511,000 shares valued at US$95.6M — a reduction of -439,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 2.44M $46.12M New
Q2 2026 2.95M $138.77M Add
Q3 2026 2.51M $95.57M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DFTX and 13F data

DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 112 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$268.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$258.4M), Deep Track Capital, LP (US$38.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DFTX

All DFTX fund holders →

FAQ

How long has Octagon Capital Advisors LP held DFTX?

Octagon Capital Advisors LP has disclosed DFTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Octagon Capital Advisors LP's current position in DFTX?

As of Q3 2026, Octagon Capital Advisors LP holds 2.51M shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $95.57M, representing 12.73% of its reported portfolio and ranking #3.

Has Octagon Capital Advisors LP been buying or selling DFTX?

In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP reduced its position in DFTX. The position peaked in Q2 2026 at 2.95M shares.

Which other funds hold DFTX?

Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Deep Track Capital, LP, among 112 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.